Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

MorphoSys

Founders Andreas Pluckthun Simon E. Moroney

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 2
Average round size
info
The average size of a deal this fund participated in
$60M
Portfolio companies 2
Rounds per year 0.07
Lead investments 0
Key employees Soon

Areas of investment

  • Therapeutics
  • Biotechnology
  • Life Science
  • Medical
  • Product Research

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Anonymous Trust California, San Francisco, United States
Asia Capital Colombo, Sri Lanka, Western Province
Capital Fund Management France, Ile-de-France, Paris
Corundum Open Innovations Herzliya, Israel, Tel Aviv
Country Garden China, Foshan, Guangdong
Dingqing Investment Beijing, Beijing, China
Grit Ventures California, Menlo Park, United States
Guangzhoushi Guoying Touzi Youxian Gongsi China, Guangdong, Guangzhou
Kyodo News Digital Chiba Prefecture, Japan, Tateyama
Luxmi Ventures -
Maersk Line Copenhagen, Denmark, Hovedstaden
Pall New York, Port Washington, United States
Rosario Capital LTD Israel, Tel Aviv, Tel Aviv District
Royal Majestics Finland, Helsinki, Southern Finland
Rubicon Venture Capital California, San Francisco, United States
The Optimas Group Nebraska, Omaha, United States
Ventura Capital Dubai, United Arab Emirates
Vivo Capital California, Palo Alto, United States
Xin Chang Electronics Technology -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Human Immunology Biosciences

Biotechnology
Life Science
Medical
Product Research
Therapeutics
$120M01 Nov 2022 San Francisco, California, United States

Adivo

Biotechnology
Therapeutics
20 Aug 2018 Germany, Bavaria, Germany

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent MorphoSys?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: